Showing results (31-40 of 144) with videos related to
Sort By:
Pageof 15
Clinical Neurology and Neurosurgery|February 1, 1994
Hospital referral of stroke patients: a survey of attitudes in general practice, and consideration of entry times for clinical trialsL Hantson, J Gheuens, L Tritsmans, et al.The Journal of Emergency Medicine|January 1, 1985
Coma as presenting manifestation of Wernicke's encephalopathyJ De Keyser, D Deleu, C Solheid, et al.Neurochemistry International|May 28, 2010
(+/-)Tetrahydroanisocycline and (+/-)tetrahydropalmatine binding to D1 and D2 dopaminergic receptors in human putamenG Vauquelin, J De Keyser, B Kanyinda, et al.Journal of Neurochemistry|October 1, 1989
In human brain two subtypes of D1 dopamine receptors can be distinguished on the basis of differences in guanine nucleotide effect on agonist bindingJ De Keyser, H Walraevens, G Ebinger, et al.Clinical Neurology and Neurosurgery|March 16, 2000
Predicting outcome from coma: man-in-the-barrel syndrome as potential pitfallJ W Elting, R Haaxma, G Sulter, et al.Neuroreport|February 24, 2001
Disappearance of beta2-adrenergic receptors on astrocytes in canine distemper encephalitis: possible implications for the pathogenesis of multiple sclerosisJ De Keyser, N Wilczak, J H Walter, et al.European Journal of Neurology|November 29, 2011
Alcohol, coffee, fish, smoking and disease progression in multiple sclerosisM B D'hooghe, P Haentjens, G Nagels, et al.Clinical Neurology and Neurosurgery|January 1, 1991
Meningoencephalitis caused by Rickettsia conoriiN De Klippel, J De Keyser, H Merckx, et al.European Journal of Neurology|June 17, 2005
Serum uric acid, dehydroepiandrosterone sulphate, and apolipoprotein E genotype in benign vs. progressive multiple sclerosisG S M Ramsaransing, D J Heersema, J De KeyserMultiple Sclerosis (Houndmills, Basingstoke, England)|May 21, 2010
Modifiable factors influencing relapses and disability in multiple sclerosisM B D'hooghe, G Nagels, V Bissay, et al.Pageof 15